Corbus Pharmaceuticals falls after trial data for lead asset
Corbus Pharmaceuticals (CRBP) stock drops 12% after mixed Phase 1 trial results for its lead cancer candidate. Read more here.
BusinessMirror6 小时
Show your love and get protected against cervical cancer this V-Day
This is an educational message sponsored by MSD Philippines. Valentine’s Day is traditionally a time for chocolates, flowers, and romantic dinners. But what if this year, you and your partner focused ...
Philippine Daily Inquirer14 小时
This Valentine’s Day, show your love and get protected against cervical cancer
Valentine’s Day is traditionally a time for chocolates, flowers, and romantic dinners. But what if this year, you and your ...
WCPO Cincinnati2 天
Hamilton Township officer fights cancer with the support of fellow officers, community
Megan Graham, an officer with the Hamilton Township, was diagnosed was cervical cancer. Now, her fellow officers and the ...
Iovance Biotherapeutics, Inc.: Iovance Biotherapeutics Appoints Dan Kirby as Chief ...
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal ...
Precigen: Successful Proof Of Platform, But Cash Worries Remain
Precigen has a market cap of $468mn and a cash runway into 2026, but needs more funds for commercialization. Check out my ...